Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cashflow Statement

EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹1,287 Cr₹971 Cr₹727 Cr₹747 Cr₹973 Cr
Adjustment ₹555 Cr₹552 Cr₹543 Cr₹492 Cr₹399 Cr
Changes In working Capital ₹-530 Cr₹-424 Cr₹51 Cr₹-292 Cr₹-292 Cr
Cash Flow after changes in Working Capital ₹1,312 Cr₹1,099 Cr₹1,321 Cr₹947 Cr₹1,079 Cr
Cash Flow from Operating Activities ₹944 Cr₹852 Cr₹1,097 Cr₹747 Cr₹768 Cr
Cash Flow from Investing Activities ₹-1,193 Cr₹-94 Cr₹-713 Cr₹-468 Cr₹-789 Cr
Cash Flow from Financing Activities ₹343 Cr₹-814 Cr₹-164 Cr₹-145 Cr₹-152 Cr
Net Cash Inflow / Outflow ₹94 Cr₹-56 Cr₹221 Cr₹134 Cr₹-172 Cr
Opening Cash & Cash Equivalents ₹-14 Cr₹44 Cr₹-175 Cr₹-308 Cr₹-350 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ----₹214 Cr
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹18 Cr₹-2.05 Cr₹-2.00 Cr₹-0.13 Cr₹0.19 Cr
Closing Cash & Cash Equivalent ₹98 Cr₹-14 Cr₹44 Cr₹-175 Cr₹-308 Cr

Compare Cashflow Statement of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹41,251.2 Cr 16.7% 12.2% 48% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,122.0 Cr 0.7% -0.3% 3.2% Stock Analytics
DIVIS LABORATORIES ₹266,424.0 Cr 4% 8.9% 54.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,914.0 Cr 3.6% -0.5% 28.8% Stock Analytics
DR REDDYS LABORATORIES ₹114,599.0 Cr 2.5% 13.6% 9.4% Stock Analytics
CIPLA ₹113,112.0 Cr 3.2% 5% -11.9% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

16.7%

12.2%

48%

SENSEX

5.5%

7.5%

-8.7%


You may also like the below Video Courses